Loading clinical trials...

Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon | Clinical Trials | Clareo Health

TERMINATEDNANCT05445258

Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon

This is a 'first in man' study to demonstrate compliance with the general safety and performance requirements of Regulation (EU) 2017/745 on medical devices (MDR) Annex I as part of the clinical evalu...

Lead sponsor: InnoRa GmbH•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment3

Start dateMay 2022

Last updatedSep 8, 2022

Locations shown

Klinik für Diagnostische und Interventionelle Radiologie Evangelisches Krankenhaus Hubertus

Berlin

Klinik für Radiologie und Nuklearmedizin Martin-Luther-Krankenhaus

Berlin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions